LIC MF Healthcare Fund

Sectoral / ThematicEquityVery High risk Rank 26 of 157

NAV · Direct-Growth

₹37.47+0.08+0.21%

As of 18 Aug 2026 · AMFI

NAV growth+15.9%

Aug ’25Aug ’26

Arthkar verdictSolid on the numbers

Returns

Mixed vs category

2 of 3 periods ahead

Cost

Average

0.96% vs NaN% peers

Volatility

Below average

15.8% vs 16.3% cat (3Y)

Consistency

Steady

positive in 5 of 7 years

Beats its Sectoral / Thematic category on 1Y & 3Y but trails on 5Y — and has been steadier than peers.

1Y return

+15.9%

+6.4 vs cat

3Y CAGR

+22.6%

+5.4 vs cat

5Y CAGR

+13.0%

-1.8 vs cat

AUM

₹88.96 Cr

fund size

Expense

0.96%

direct plan

Volatility 3Y

15.8%

▼ vs 16.3%

Go deeper on LIC MF Healthcare Fund

Two data-only views, computed from this fund's real NAV history — no projections.

LIC MF Healthcare Fund SIP returnsWhat ₹1,000–₹25,000/month actually became, 3 to 20 years — real results, with drawdowns and an FD comparison.LIC MF Healthcare Fund real oddsYour real chances over every start date in history — how often it made money and beat a fixed deposit.

In plain English

LIC MF Healthcare Fund is a Sectoral / Thematic scheme from LIC. The portfolio is ~93% in equities with 7% kept in cash and short-term debt. Long-run track record: about 13.0% CAGR over 5 years. Volatility is typical for equity — 20–30 % drawdowns happen during market stress. Worst historical drawdown: -22% in Mar 2023, recovered in 8 months. Wrong fit if you need this money in less than 7 years.

Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.

NAV history

Showing Direct · Growth · INF397L01LK4

NAV (Direct-Growth)

₹37.4718

Last 1Y

+15.88%

Aug 25Min ₹29.62 · Max ₹37.85 · 247 ptsAug 26

Drawdown stories

The crashes you should know about — and how long the fund took to recover.

Mar 2023

-22.2%

Peak ₹21.05 on 15 Sept 2021 → trough ₹16.37 on 14 Mar 2023 (18 months down).

Recovered in 8 months· 8 Nov 2023

Mar 2020

-19.3%

Peak ₹11.65 on 20 Feb 2020 → trough ₹9.40 on 23 Mar 2020 (1 months down).

Recovered in 1 months· 8 Apr 2020

Feb 2025

-15.1%

Peak ₹33.28 on 5 Dec 2024 → trough ₹28.26 on 28 Feb 2025 (3 months down).

Recovered in 14 months· 6 May 2026

Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.

Honesty score

A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.

Honesty score

4 / 5

Solid scheme on the dimensions we check. No red flags.

Expense ratio
0.96% — typical for category.
AUM size
₹89 Cr.
Sector concentration
Top 3 sectors = 96.1% — heavy concentration risk.

Computed from expense ratio, AUM, sector concentration and SEBI mandate compliance. No paid review.

Performance

Returns for various periods, with category average and peer rank.

Period	Returns	Category avg	Rank
1W	-1.01%	-0.40%	232/ 286
1M	+4.54%	+2.47%	58/ 286
3M	+9.47%	+8.01%	97/ 286
6M	+19.87%	+6.33%	16/ 278
YTD	+17.25%	+6.03%	29/ 273
1Y	+15.88%	+9.52%	59/ 258
2Y	+12.12%	+5.82%	25/ 203
3Y	+22.57%	+17.18%	26/ 157
5Y	+12.95%	+14.76%	85/ 125
7Y	+21.15%	+18.88%	37/ 104

Portfolio composition

Asset allocation

Equity92.92%
Cash7.08%

By market cap

Large cap33.13%
Mid cap29.02%
Small cap34.34%
Others3.51%

Concentration

Holdings

Avg market cap

₹65.9K Cr

Top 10 stocks

55.71%

Top 5 stocks

34.12%

Top 3 sectors

96.12%

Top holdings

Top 15 positions by weight, latest disclosure.

#InstrumentSectorWeight

1
Sun Pharmaceuticals Industries Ltd
—11.77%
1
Sun Pharmaceuticals Industries Ltd
—11.22%
2
Torrent Pharmaceuticals Ltd
—7.08%
3
Apollo Hospitals Enterprise Ltd
—6.84%
2
Apollo Hospitals Enterprise Ltd
—6.52%
3
Torrent Pharmaceuticals Ltd
—6.50%
4
Aurobindo Pharma Ltd
—5.21%
4
Aurobindo Pharma Ltd
—5.15%
5
Divi's Laboratories Ltd
—4.74%
6
Fortis Healthcare Ltd
—4.70%
5
Divi's Laboratories Ltd
—4.68%
7
Neuland Laboratories Ltd
—4.59%
8
OneSource Specialty Pharma Ltd
—4.56%
6
Fortis Healthcare Ltd
—4.37%
9
Piramal Pharma Ltd
—4.33%

Fundamentals (vs category)

Portfolio-weighted ratios, compared with the category average.

MetricFundCategory avgDiff

P/E ratio45.9841.09+4.89
P/B ratio5.885.83+0.05
Price / Sales6.455.71+0.74
Price / Cash Flow33.4830.54+2.94
Dividend yield0.49%0.63%-0.14
Return on equity (ROE)15.36%16.57%-1.21

Risk metrics

Standard deviation, Sharpe, Sortino, Beta — all vs category average.

Metric1Y3Y5YCat 1YCat 3YCat 5Y

Standard deviation
Volatility — lower means steadier returns.
16.2216.0615.2714.9216.2915.44
Sharpe ratio
Risk-adjusted return — higher is better.
0.410.980.460.480.980.58
Sortino ratio
Like Sharpe but only counts downside volatility.
0.641.730.720.831.710.94
Beta
1 = moves with the market. <1 = less volatile.
0.940.940.930.940.950.94

Peers in Sectoral / Thematic

Other schemes in the same SEBI category, ranked by AUM.

Peer fundAUM1Y3Y CAGRExpense

Peers in same SEBI category, ranked by AUM. Compare any →

Available plans & options

PlanOptionFull nameISIN

Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.

NEW

See your SIP through Indian market history

Pick a fund and a start year — get a 60-second cinematic replay of every crash, boom, and headline with your money in it. Real NAV data, no “assumed 12%” lies.

Try Wealth Time Machine

AI · Free

Find what's really inside your funds

Upload your CAS PDF — get instant stock concentration, hidden fund overlap, sector risk, and 3 key insights, written by AI in plain English.

Run Portfolio X-Ray